US OptionsDetailed Quotes
VKTX241129P90000
- 0.00
- 0.000.00%
15min DelayClose Nov 27 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest90.00Strike Price0.00Turnover761.85%IV-65.11%PremiumNov 29, 2024Expiry Date35.49Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9752Delta0.0044Gamma1.53Leverage Ratio-0.9464Theta-0.0007Rho-1.49Eff Leverage0.0010Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet